Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring. The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions. Philips’ patient care management solutions for the hospital include real-time patient monitoring, therapeutic devices, telehealth and informatics.
Read the full article: Philips Completes the Acquisition of Biotelemetry, Inc. //
Source: https://www.globenewswire.com/news-release/2021/02/09/2172389/0/en/Philips-completes-the-acquisition-of-BioTelemetry-Inc.html